相关实验视频

Updated: Jun 13, 2025

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

亲体分子在生物医学应用中的最新进展

Liuyanlin Zhang¹, Houjin Zhang¹

¹Department of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, MOE Key Laboratory of Molecular Biophysics, Wuhan 430074, China.

Bioorganic & medicinal chemistry

|September 15, 2024

概括

来自蛋白质A的亲体分子是多功能工具,可以替代医学中的抗体. 这篇评论强调了他们最近在癌症成像和向药物输送方面的进展.

科学领域:

生物化学生物化学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

亲体分子是来自Staphylococcal Protein A的Z域的小型工程蛋白质.
由于其独特的特性,它们在各种生物医学应用中作为抗体的替代品.
已开发出用于临床的治疗性附体分子,证明了它们的翻译潜力.

研究的目的:

审查近期 (过去五年) 关于附体分子技术和应用的进展.
专注于附体分子在医学成像,特别是瘤学中的潜力.
探索它们在向药物输送和组合疗法中的应用.

主要方法:

文献综述专注于过去五年内发表的研究.
在分子成像和癌症治疗中研究附体分子的研究分析.
检查涉及向药物输送和纳米颗粒合物的应用程序.

主要成果:

亲体分子显示出在瘤学中分子成像的显著前景.
它们在有针对性地提供有毒药物和治疗剂方面是有效的.
它们与纳米颗粒的集成增强了传递和成像能力.
亲体分子越来越多地被用作各种生物医学应用中的向配体.

结论:

亲体分子在生物医学应用中比传统抗体提供了实质性的优势.
它们在癌症成像和向治疗方面的潜力是显著的,并且正在迅速扩大.
持续的研究和开发可能会扩大它们在瘤学及其他领域的临床实用性.

关键词:

附属体附属体附属体附属体分子成像学分子成像学有针对性的治疗.

更多相关视频

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...